References
Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: Comparison to CR using integrated PET/MRI. J Nucl Cardiol. 2016. doi:10.1007/s12350016-0616-y.
Wada K, Niitsuma T, Yamaki T, Masuda A, Ito H, Kubo H, et al. Simultaneous cardiac imaging to detect inflammation and scar tissue with 18F-fluorodeoxyglucose in cardiac sarcoidosis. J Nucl Cardiol. 2016;23:1180–2.
Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;17:1683–90.
Disclosure
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kiko, T., Masuda, A., Nemoto, A. et al. Cardiac sarcoidosis after glucocorticoid therapy evaluated by 18F-fluorodeoxyglucose PET/MRI. J. Nucl. Cardiol. 25, 685–687 (2018). https://doi.org/10.1007/s12350-017-1066-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-017-1066-x